News | July 24, 2007

Accuray Creates Noninvasive Treatment System for Lung Tumors

July 25, 2007 – Accuray Inc. featured its Xsight Lung Tracking System designed for the non-invasive treatment of lung tumors, at the American Association of Physicists in Medicine (AAPM) annual meeting in Minneapolis, MN.

Working seamlessly with Accuray’s CyberKnife System and Synchfony Respiratory Tracking System, the Xsight Lung Tracking system uses the body’s soft tissue to directly track targets with radiosurgical accuracy. The system delivers highly specialized soft tissue tracking by using the actual image intensity of the lung tumor to target the beam, therefore eliminating the need in some cases for implanted fiducial markers.

An additional tool in the treatment of lunch cancer is Accuray’s Monte Carlo dose calculation methodology, which is currently pending FDA 510(k) clearance. Accuray’s Monte Carlo dose calculation is designed to be fast and accurate, reportedly enabling clinicians to more precisely determine, in a matter of minutes, the intensity of radiation to be delivered in areas where tissue densities vary.

For more information: www.accuray.com

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers. #ASTRO18 #ASTRO2018

A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.

Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American Societ...
Victoria Advisory Committee for Proton Therapy Launched at ASTRO 2018
News | Proton Therapy | October 29, 2018
At the 2018 American Society for Radiation Oncology (ASTRO) annual meeting, IBA announced the launch of the Victoria...
Beaumont Hospital Cancer Institute Performs First Irradiation of Spot Scanning Proton Arc Therapy Plan
News | Proton Therapy | October 25, 2018
IBA announced the first irradiation of a Spot Scanning Proton Arc (SPArc) plan at the Beaumont Health Proton Therapy...
Varian Introduces New ProBeam 360° Proton Therapy System
News | Proton Therapy | October 23, 2018
Varian announced its new single-room proton therapy system, ProBeam 360°, at the 2018 American Society of Radiation...
Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018

Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018.

Feature | Stereotactic Body Radiation Therapy (SBRT) | October 23, 2018 | By Greg Freiherr
With its shorter course of treatment,...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t
Feature | Proton Therapy | October 04, 2018 | By Adam Conner-Simons
Investigating inside the human body often requires cutting open a patient or swallowing long tubes with built-in...